{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:19:46Z","timestamp":1707265186345},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T00:00:00Z","timestamp":1159228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,6,14]]},"DOI":"10.1007\/s11255-006-9082-9","type":"journal-article","created":{"date-parts":[[2006,9,25]],"date-time":"2006-09-25T15:33:13Z","timestamp":1159198393000},"page":"685-689","source":"Crossref","is-referenced-by-count":2,"title":["Anaemia correction in predialysis elderly patients: influence of the antihypertensive therapy on darbepoietin dose"],"prefix":"10.1007","volume":"39","author":[{"given":"Pedro Le\u00e3o","family":"Neves","sequence":"first","affiliation":[]},{"given":"Alexandre","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Morgado","sequence":"additional","affiliation":[]},{"given":"Alfonso","family":"Iglesias","sequence":"additional","affiliation":[]},{"given":"Herm\u00ednio","family":"Carrasqueira","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Fa\u00edsca","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Ana P.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,9,26]]},"reference":[{"key":"9082_CR1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0025-7125(16)31215-9","volume":"67","author":"AH Samiy","year":"1984","unstructured":"Samiy AH (1984) Renal disease in the elderly. Med Clin North Am 67:463\u2013480","journal-title":"Med Clin North Am"},{"issue":"Suppl","key":"9082_CR2","first-page":"2","volume":"6","author":"DG Oreopoulos","year":"1990","unstructured":"Oreopoulos DG (1990) The aging kidney. Adv Perit Dial 6(Suppl):2\u20135","journal-title":"Adv Perit Dial"},{"key":"9082_CR3","unstructured":"Raine AEG, Margreiter R, Brunner FP et al (1992) Report on management of renal failure in europe, XXII, 1991. Nephrol Dial Transplant 7(Suppl 2): 7\u201335"},{"issue":"Suppl 2","key":"9082_CR4","first-page":"S4","volume":"39","author":"Annual report","year":"2002","unstructured":"Annual report (2002) ESRD clinical performance measures project. Am J Kidney Dis 39(Suppl 2):S4\u2013S98","journal-title":"Am J Kidney Dis"},{"key":"9082_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1985.109","volume":"28","author":"JW Eschbach","year":"1985","unstructured":"Eschbach JW, Adamson JW (1985) Anemia of end-stage renal disease (ESRD). Kidney Int 28:1\u20135","journal-title":"Kidney Int"},{"key":"9082_CR6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.1997.91","volume":"51","author":"AJ Erslev","year":"1997","unstructured":"Erslev AJ, Besarab A (1997) Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 51:622\u2013630","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"9082_CR7","first-page":"ii6","volume":"19","author":"Revised European Best Practice Guidelines","year":"2004","unstructured":"Revised European Best Practice Guidelines (2004) For the management of anaemia in patients with chronic renal failure. Section II: targets for anaemia treatment. Nephrol Dial Transplant 19(Suppl 2):ii6\u2013ii15","journal-title":"Nephrol Dial Transplant"},{"key":"9082_CR8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/ki.1982.233","volume":"22","author":"JH Acosta","year":"1982","unstructured":"Acosta JH (1982) Hypertension in chronic renal disease. Kidney Int 22:702\u2013712","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"9082_CR9","first-page":"S45","volume":"16","author":"A Coca","year":"1998","unstructured":"Coca A (1998) Actual blood pressure control: are we doing things right ? J Hypertens 16(Suppl 1):S45\u2013S51","journal-title":"J Hypertens"},{"key":"9082_CR10","doi-asserted-by":"crossref","unstructured":"Juan PC, Weiliang C, Stavros L, Patrick V et al (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366:2026\u20132033","DOI":"10.1016\/S0140-6736(05)67814-2"},{"key":"9082_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Albert D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zuchelli P (1996) Angiotensin converting enzyme inhibition in progressive renal insufficiency study group. Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of renal insufficiency. N Engl J Med 334:939\u2013945","journal-title":"N Engl J Med"},{"key":"9082_CR12","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.V9122223","volume":"9","author":"J Plum","year":"1998","unstructured":"Plum J, Blunten B, Nemeth R, et al (1998) Effect of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. J Am Soc Nephrol 9:2223\u20132234","journal-title":"J Am Soc Nephrol"},{"key":"9082_CR13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","volume":"21","author":"Guidelines Committee","year":"2003","unstructured":"Guidelines Committee (2003) 2003 European society of hypertension\u2014European society of cardiology guidelines for the management of hypertension. J Hypertens 21:1011\u20131053","journal-title":"J Hypertens"},{"key":"9082_CR14","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"A Chobanian","year":"2003","unstructured":"Chobanian A, Bakris GL, Black HR, et al (2003) The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. J Am Med Assoc 289:2560\u20132572","journal-title":"J Am Med Assoc"},{"key":"9082_CR15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000166851","volume":"4","author":"H Hirakata","year":"1984","unstructured":"Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, Omae T (1984) Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 4:355\u2013360","journal-title":"Am J Nephrol"},{"key":"9082_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0140-6736(05)60259-0","volume":"352","author":"A Schwarzbeck","year":"1998","unstructured":"Schwarzbeck A, Wittenmeier KW, Hallfritzsch U (1998) Anaemia in dialysis patients as a side-effect of sartanes. Lancet 352:286","journal-title":"Lancet"},{"key":"9082_CR17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000072705","volume":"23","author":"M Naito","year":"2003","unstructured":"Naito M, Kawashima A, Akiba T, Takanashi M, Nihei H (2003) Effects of an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients. Am J Neprol 23:287\u2013293","journal-title":"Am J Neprol"},{"key":"9082_CR18","doi-asserted-by":"crossref","unstructured":"Gault MH, Longerich LL, Harnett JD, Wesolowski C (1992) Predicting glomerular function from adjusted serum creatinine (editorial). Nephron 62:249","DOI":"10.1159\/000187054"},{"key":"9082_CR19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/ndt\/14.7.1732","volume":"14","author":"K Kalantar-Zadeh","year":"1999","unstructured":"Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC (1999) A modified quantitative subjective global assessmet of nutrition for dialysis patients. Nephrol Dial Transplant 14:1732\u20131738","journal-title":"Nephrol Dial Transplant"},{"key":"9082_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000190270","volume":"77","author":"S Kuriyama","year":"1997","unstructured":"Kuriyama S, Tomonari H, Yoshida H et al (1997) Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77:176\u2013185","journal-title":"Nephron"},{"key":"9082_CR21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0272-6386(12)80025-4","volume":"16","author":"PW Eggers","year":"1990","unstructured":"Eggers PW (1990) Health care policies\/economics of the geriatric renal population. Am J Kidney Dis 16:384\u2013391","journal-title":"Am J Kidney Dis"},{"key":"9082_CR22","first-page":"85","volume-title":"Ethics and the kidney","author":"EA Friedman","year":"2001","unstructured":"Friedman EA (2001) Must (should) all ESRD patients be treated? In: Levinsky NG (ed) Ethics and the kidney. Oxford University Press, Oxford, pp 85\u201398"},{"key":"9082_CR23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ageing\/23.5.356","volume":"23","author":"PL Neves","year":"1994","unstructured":"Neves PL, Sousa A, Bernardo I et al (1994) Chronic haemodialysis for very old patients. Age Ageing 23:356\u2013359","journal-title":"Age Ageing"},{"key":"9082_CR24","first-page":"505","volume":"255","author":"KW Woodhouse","year":"1988","unstructured":"Woodhouse KW, Wynne H, Baille S et al (1988) Who are the frail elderly? Q J Med 255:505\u2013506","journal-title":"Q J Med"},{"issue":"Suppl 2","key":"9082_CR25","first-page":"ii32","volume":"19","author":"Revised European Best Practice Guidelines","year":"2004","unstructured":"Revised European Best Practice Guidelines (2004) For the management of anaemia in patients with chronic renal failure. Section IV: failure to respond to treatment. Nephrol Dial Transplant 19(Suppl 2):ii32\u2013ii36","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"9082_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/16.suppl_3.3","volume":"16","author":"JC Egrie","year":"2001","unstructured":"Egrie JC, Browne JK (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 16(Suppl 3):3\u201313","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-006-9082-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9082-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T14:50:12Z","timestamp":1627829412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-006-9082-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,26]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6,14]]}},"alternative-id":["9082"],"URL":"https:\/\/doi.org\/10.1007\/s11255-006-9082-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,26]]}}}